Connect with us

Featured

Stock Price Fresh Friday Feed For May 3, 2019

A. Lawrence

Published

on

stormtrooper stock chart

Let me be the first to say may the fourth be with you (tomorrow). But until then, we’ve got one more day to profit. The IPO arena is heating up right now with the latest string of high flying, highly volatile private to public transactions. What this could signal is that Wall Street isn’t afraid of anything right now…and that could be a clear sign that MicroCap stocks will be on the agenda. To get you ready to close out the first week of May, we’ve got some fresh Friday reads for you:

This New Technology Could Transform A Multi-Billion-Dollar Industry!

On an almost daily basis, news coverage shows us that we are living constantly at risk. The U.S Justice Department defines a “mass casualty event” as any occurrence of a mass shooting, bombing, or other crime resulting in multiple fatalities. In 2019, there have already been over 80 US mass shootings and sadly we just witnessed another at the start of May…But what if there was a way to help prevent these types of events from taking place? If there were ever a time to find a solution, now is that time & one company could have a clear answer!

CLICK HERE & READ OUR FULL REPORT


ParcelPal (PTNYF) (PKG) Welcomes Ontario MP Ben Lobb to the Advisory Board of Directors

VANCOUVER, British Columbia , May 3, 2019 /CNW/ — ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (PKG.CN) (PT0.F) (PTNYF) is pleased to welcome Ontario MP Ben Lobb as an advisor to the Board of Directors.

Click Here For Full Press Release


Liberty (SCAN.V) Announces Appointment of Ron Solanki as VP Operations of its US Subsidiary and Provides Marketing Update

Vancouver, British Columbia–(Newsfile Corp. – May 3, 2019) – Liberty Defense Holdings, Ltd. (TSXV: SCAN) (FSE: LD2) (“Liberty“) is pleased to announce the appointment of Ron S. Solanki as Vice President, Operations of its US subsidiary, Liberty Defense Technologies Inc., and provide an update of marketing activities.

Click Here For Full Press Release


Healthcare Weighing Heavily On US Outlook – Clear Opportunity For Health Tech To Step In?

Republicans and Democrats battle with the government as they want the health care plan to be revised. The battle over which act should replace the Affordable Care Act is on. The common claims are not in favor across the entire U.S. health care system. Many want a revised law, which would enact major changes such as protecting pre-existing conditions and hastening the rising prescription costs. It’s time for a change and some companies are already getting ahead of the curve. That could mean big opportunities ahead for the public

Click Here & Read More


Trump Threatens Lawsuit Against Big U.S Banks

Donald Trump, the President of one of the most powerful countries, has sued Capital One (COF) & Deutsche Bank (DB) in order to restrict them from reverting back to the subpoenas issued by the House.

For More On This Story, Click Here


Disclaimer:MIDAM VENTURES LLC has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to May 1, 2019. We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares.

Pursuant to an agreement between MIDAM VENTURES, LLC and Liberty Defense Holdings Inc. Midam was hired for a period from 04/15/2018 – 5/15/2019 to publicly disseminate information about Liberty Defense Holdings Inc. including on the Website and other media including Facebook and Twitter. We were paid $350,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of Liberty Defense Holdings Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full disclaimer.

Continue Reading
Click to comment

Biotechnology

Will Biotech Stocks Soar Into 2020?

Joe Samuel

Published

on

best biotech stocks to trade now

The stock market has been on a wild ride this year and December has shown no difference. When it comes down to it, making money in the stock market is simple. But it isn’t easy; let me explain.

For instance, if a sector is on the upward trajectory then it makes complete sense to have a look at some of the stocks in that arena. But then again, even if the sector is hot, it doesn’t mean every stock within it is.

Regardless, among the sectors that have shown impressive growth over the past few years biotech remains positive. and many investors have managed to make handsome returns. Here is a look at two biotech stocks that are worth considering at this point.

Tonix Pharmaceuticals Holding

The first biotech stock that could be out into the watch list is that of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) after the company made an important announcement. Tonix announced that it has been granted a patent by the European Patent Office for “Eutectic Formulations of Cyclobenzaprine Hydrochloride and Mannitol”.

The patent gives Tonix access to as many as 14 claims and also gives the company exclusive rights up until 2034. The development is a significant one and could have far-reaching implications for Tonix’s business in the years to come.The news was well-received by the markets as well and the stock rallied by as much as 23% on Thursday.

VBI Vaccines

The other stock that could be taken under consideration is the VBI Vaccines Inc (NASDAQ:VBIV). The company made a major announcement with regards to the Phase 1/2A study of its cancer vaccine immunotherapeutic In recurrent glioblastoma (GBM) patients medicine VB1-1901.

The company announced that it presented the data regarding the medicine at the 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. The event in question is an influential one and is a substantial achievement for VBI. The stock rallied by as much as 50%.

Continue Reading

Featured

Stock Price Newsletter – December 13, 2019

Joe Samuel

Published

on

stock market news

StockPrice Special Report: The $40 Billion Dollar Content Gold Rush

Click For Full Report


2 Biotech Stocks To Watch Before Next Week

See For Yourself


Streaming Wars and the Future of Companies Involved

Has The Time Come?

Continue Reading

Biotechnology

2 Biotech Stocks To Watch Before Next Week

A. Lawrence

Published

on

stock_price_medicine

Biotech has been one of the hottest sectors to invest in for quite a few years. Nowadays, investors are almost always on the lookout for the next big thing from among those stocks. However, when it comes to identifying stocks, an investor needs to do his fair share of research and then decide on his next course of action.

Additionally, one could also watch the market closely and keep track of the latest movements in penny stocks in order to identify potential winners. Here is a look at two biotech stocks which could be of interest to investors.

Biotech Stocks To Watch: Marinus Pharmaceuticals

The first biotech stock to bring under consideration is Marinus Pharmaceuticals Inc (NASDAQ:MRNS)  which has made significant gains on Wednesday on the back of an important announcement.

top biotech stocks to buy

On Wednesday, the company announced that it is going to make a simultaneous public offering of its common stock and private placement. The total value of these two offerings is going to be $65 million. The news resulted in a 38% bump in the stock price in yesterday’s trading session.

Earlier this week, the company announced that it has started its Phase 2 trial for its product ganaxolone as well. The medicine in question is supposed to treat tuberous sclerosis complex and it goes without saying that it is a significant milestone for Marinus.

Biotech Stocks To Watch: Diffusion Pharmaceuticals

top biotech stocks to buy now

The other biotech stock that could be worth tracking is that of Diffusion Pharmaceuticals Inc (NASDAQ:DFFN). The company announced positive data with regards to the Phase 3 study its product Trans Sodium Crocetinate (TSC) plus standard of care (SOC). The data showed that there was an improvement in the condition of patients suffering from inoperable glioblastoma multiforme.

It proved to be a major trigger for the Diffusion stock and after the announcement was made on Tuesday, the stock has rallied by as much as 31.40%. It is a stock that could be worth watching over the coming days.

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com